Skip to main content
. 2010 Apr 13;10:136. doi: 10.1186/1471-2407-10-136

Table 2.

Frequency of immunostaining and KRAS mutations among breast cancer tumors.

Subtype Samples CK5/6+ (%) EGFR+ (%) CK/EGFR+ (%)* KRAS mut (%)
TN 35 17 (48.6) 25 (71.4) 15 (42.8) 0 (0.0)
BS 27 17 (63.0) 25 (92.6) 15 (55.5) 0 (0.0)

*Positive staining for both CK5/6 and EGFR

Abbreviations: TN, triple-negative; BS, basal-like; CK, cytokeratin 5/6; KRAS mut, mutant KRAS